Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP-
dc.contributor.authorPAMNANI, Shitaldas J.-
dc.contributor.authorSUDENGA, Staci L.-
dc.contributor.authorROLLISON, Dana E.-
dc.contributor.authorINGLES, Donna J.-
dc.contributor.authorABRAHAMSEN, Martha-
dc.contributor.authorVILLA, Luisa L.-
dc.contributor.authorLAZCANO-PONCE, Eduardo-
dc.contributor.authorHUANG, Yangxin-
dc.contributor.authorBORENSTEIN, Amy-
dc.contributor.authorGIULIANO, Anna R.-
dc.identifier.citationJOURNAL OF INFECTIOUS DISEASES, v.218, n.8, p.1219-1227, 2018-
dc.description.abstractBackground. The purpose of this study was to assess genital recurrence of human papillomavirus (HPV) genotypes included in the 9-valent vaccine and to investigate factors associated with recurrence among men in the HPV Infection in Men (HIM) Study. Methods. Men were followed every 6 months for a median of 3.7 years. HPV genotypes were detected using Roche linear array. Factors associated with type-specific HPV recurrence (infections occurring after a >= 12-month infection-free period) were assessed. Results. In type-specific analyses, 31% of prior prevalent and 20% of prior incident infections recurred. Among prevalent infections, HPV types 52, 45, 16, 58, and 6 and among incident infections, HPV types 58, 52, 18, 16, and 11 had the highest rates of recurrence. New sexual partners (male or female) and frequency of sexual intercourse with female partners were associated with HPV-6, -16, -31, and -58 infection recurrence. In grouped analyses, lifetime and new male sexual partners were associated with recurrence of prior incident infection with any of the 9 HPV types. Conclusions. Recurrence of genital HPV infections is relatively common among men and associated with high-risk sexual behavior. Further studies are needed to understand the role of HPV recurrence in the etiology of HPV-associated diseases.-
dc.description.sponsorshipNCI NIH HHS [P30 CA076292]-
dc.relation.ispartofJournal of Infectious Diseases-
dc.subjecthuman papillomavirus-
dc.subjectHIM Study-
dc.subject.otherintraepithelial neoplasia-
dc.subject.otherpositive women-
dc.titleRecurrence of Genital Infections With 9 Human Papillomavirus (HPV) Vaccine Types (6, 11, 16, 18, 31, 33, 45, 52, and 58) Among Men in the HPV Infection in Men (HIM) Study-
dc.rights.holderCopyright OXFORD UNIV PRESS INC-
dc.subject.wosInfectious Diseases-
dc.type.categoryoriginal article-
dc.type.versionpublishedVersion-, Shitaldas J.:Brandon Reg Hosp, Grad Med Educ, Brandon, FL USA-, Staci L.:H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA; Vanderbilt Univ, Med Ctr, Dept Epidemiol, Nashville, TN USA-, Dana E.:H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA-, Donna J.:Vanderbilt Inst Global Hlth, Nashville, TN USA-, Martha:H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA-, Eduardo:Univ Sao Paulo, Sch Med, Sao Paulo, Brazil; Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico-, Yangxin:Univ S Florida, Dept Epidemiol & Biostat, Tampa, FL USA-, Amy:Univ S Florida, Dept Epidemiol & Biostat, Tampa, FL USA-, Anna R.:H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA-
hcfmusp.relation.referenceArroyo LS, 2013, J CLIN VIROL, V58, P437, DOI 10.1016/j.jcv.2013.07.013-
hcfmusp.relation.referenceBarzona L, 2011, J CLIN VIROL, V52, P93, DOI 10.1016/j.jcv.2011.07.006-
hcfmusp.relation.referenceBouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8-
hcfmusp.relation.referenceRodriguez AC, 2012, INT J CANCER, V131, P1874, DOI 10.1002/ijc.27418-
hcfmusp.relation.referenceFranceschi S, 2002, BRIT J CANCER, V86, P705, DOI 10.1038/sj/bjc/6600194-
hcfmusp.relation.referenceGiuliano AR, 2008, CANCER EPIDEM BIOMAR, V17, P2036, DOI 10.1158/1055-9965.EPI-08-0151-
hcfmusp.relation.referenceGiuliano AR, 2015, INT J CANCER, V136, P2752, DOI 10.1002/ijc.29082-
hcfmusp.relation.referenceGiuliano AR, 2011, LANCET, V377, P932, DOI 10.1016/S0140-6736(10)62342-2-
hcfmusp.relation.referenceGravitt Patti E, 2012, Open Virol J, V6, P198, DOI 10.2174/1874357901206010198-
hcfmusp.relation.referenceGravitt PE, 1998, J CLIN MICROBIOL, V36, P3020-
hcfmusp.relation.referenceInsinga RP, 2010, CANCER EPIDEM BIOMAR, V19, P1585, DOI 10.1158/1055-9965.EPI-09-1235-
hcfmusp.relation.referenceJoura EA, 2015, NEW ENGL J MED, V372, P711, DOI 10.1056/NEJMoa1405044-
hcfmusp.relation.referenceLu BB, 2012, CANCER RES, V72, P676, DOI 10.1158/0008-5472.CAN-11-0751-
hcfmusp.relation.referenceMoscicki AB, 2013, J INFECT DIS, V208, P403, DOI 10.1093/infdis/jit175-
hcfmusp.relation.referencePamnani SJ, 2016, CANCER RES, V76, P6066, DOI 10.1158/0008-5472.CAN-16-0224-
hcfmusp.relation.referencePartridge JM, 2007, J INFECT DIS, V196, P1128, DOI 10.1086/521192-
hcfmusp.relation.referencePerez-Gallego L, 2001, AM J CLIN PATHOL, V116, P143-
hcfmusp.relation.referenceRositch AF, 2012, CANCER RES, V72, P6183, DOI 10.1158/0008-5472.CAN-12-2635-
hcfmusp.relation.referenceSmith JS, 2011, J ADOLESCENT HEALTH, V48, P540, DOI 10.1016/j.jadohealth.2011.03.010-
hcfmusp.relation.referenceStevens MP, 2006, J CLIN MICROBIOL, V44, P2428, DOI 10.1128/JCM.02608-05-
hcfmusp.relation.referenceStrickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073-
hcfmusp.relation.referenceTheiler RN, 2010, OBSTET GYNECOL, V115, P1150, DOI 10.1097/AOG.0b013e3181e00927-
hcfmusp.relation.referenceTrottier H, 2010, CANCER RES, V70, P8569, DOI 10.1158/0008-5472.CAN-10-0621-
hcfmusp.relation.referenceWiner RL, 2011, CANCER EPIDEM BIOMAR, V20, P699, DOI 10.1158/1055-9965.EPI-10-1108-
Appears in Collections:

Artigos e Materiais de Revistas Científicas - FM/MDR
Departamento de Radiologia - FM/MDR

Artigos e Materiais de Revistas Científicas - LIM/24
LIM/24 - Laboratório de Oncologia Experimental

Files in This Item:
File Description SizeFormat 
  Restricted Access
publishedVersion (English)219.29 kBAdobe PDFView/Open Request a copy

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.